Skip to main content
TipRanks
Go Ultimate75% OFF

Ocumetics Technology Corp (2QB0) Stock Price & Analysis

0 Followers

2QB0 Stock Chart & Stats

€0.20€0.00(0.00%)
At close: 5:30 PM GMT+1
€0.3€0.325€0.35€0.375Jun 22Jul 10Sep 3
Day’s Range
EUR 0.20 - EUR 0.20
52-Week Range
EUR 0.20 - EUR 0.54
Previous Close
EUR 0.20
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 34.33M
Enterprise Value
EUR 63.76M
Total Cash (Recent Filing)
EUR 88.74K
Total Debt (Recent Filing)
EUR 4.31M
Price to Earnings (P/E)
―
Beta
-0.34
Next Earnings
Dec 01, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Focused Ophthalmology Platform

A focused ophthalmology strategy gives the company a clearly defined product area and development objective. Concentrating resources on vision-correction technology may support specialized expertise and disciplined commercialization planning if the platform advances through clinical and regulatory stages.

Defined Product Target

The Bionic Lens provides a specific technology target rather than a broad or unfocused research program. If development and approvals progress, its intended role as an alternative to existing correction options could create a distinct commercial opportunity in ophthalmic implants.

Active Development Program

Continued research, regulatory preparation, and commercialization planning indicate that the company is maintaining a coordinated pathway toward potential product launch. This preserves the possibility of future operating scale, although success depends on advancing beyond development into commercial revenue.

Bears Say

No Commercial Revenue

Zero revenue shows that the business has not yet converted its technology program into commercial sales. Without an established revenue stream, funding for research, regulatory work, and operations must continue without internal sales support, making progress dependent on future commercialization.

Widening Losses

The widening net loss indicates that expenses are increasing faster than the company’s ability to generate income. Persistent and larger losses can consume capital over the next several quarters, reduce financial flexibility, and make eventual profitability more dependent on successful product commercialization.

Weak Capitalization And Cash Burn

Negative equity, substantial debt relative to assets, and ongoing cash burn create a fragile financial base. The company may need continued external funding to sustain operations, increasing financing and dilution risk while limiting its capacity to absorb delays in development or regulatory progress.

Ocumetics Technology Corp News

2QB0 FAQ

What was Ocumetics Technology Corp’s price range in the past 12 months?
Ocumetics Technology Corp lowest stock price was €0.20 and its highest was €0.54 in the past 12 months.
What is Ocumetics Technology Corp’s market cap?
Ocumetics Technology Corp’s market cap is €34.33M.
When is Ocumetics Technology Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ocumetics Technology Corp’s earnings last quarter?
Ocumetics Technology Corp released its earnings results on Aug 28, 2026. The company reported -€0.002 earnings per share for the quarter.
Is Ocumetics Technology Corp overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Ocumetics Technology Corp pay dividends?
Ocumetics Technology Corp does not currently pay dividends.
What is Ocumetics Technology Corp’s EPS estimate?
Ocumetics Technology Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ocumetics Technology Corp have?
Ocumetics Technology Corp has 143,983,700 shares outstanding.
What happened to Ocumetics Technology Corp’s price movement after its last earnings report?
Ocumetics Technology Corp reported an EPS of -€0.002 in its last earnings report. Following the earnings report the stock price went down -1.77%.
Which hedge fund is a major shareholder of Ocumetics Technology Corp?
Currently, no hedge funds are holding shares in DE:2QB0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology